By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Clinical Data is considering selling off its genetic testing and biomarker development business, including its CLIA lab, according to a filing with the US Securities and Exchange Commission.
Registering provides access to this and other free content.
Already have an account?Login Now.
Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.
By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.
Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.
In Nature this week: a Danish reference genome, and more.